Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia

FASEB Journal

Volumn 19, Issue 11, 2005, Pages 1422-1430

  Funasaka, Tatsuyoshi ^a   Yanagawa, Takashi ^a   Hogan, Victor ^a   Raz, Avraham ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Hypoxia inducible factor 1; Phosphoglucose isomerase; VEGF

Indexed keywords

AUTOCRINE MOTILITY FACTOR; GLUCOSE 6 PHOSPHATE ISOMERASE; PHOSPHATIDYLINOSITOL 3 KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANAEROBIC GLYCOLYSIS; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CELL DIFFERENTIATION; CELL MOTILITY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HUMAN CELL; HYPOXIA; METASTASIS; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANOXIA; AUTOCRINE MOTILITY FACTOR; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INDAZOLES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 24644488689     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.05-3699com     Document Type: Article

References (46)

1. Semenza, G. L. (2003) Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732
2. Dang, C. V., and Semenza, G. L. (1999) Oncogenic alterations of metabolism. Trends Biochem. Sci. 24, 68-72
3. Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., and Poellinger, L. (1999) Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274, 6519-6525
4. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578
5. Sivitz, W. I., Lund, D. D., Yorek, B., Griver-McKay, M., and Schmid, P. G. (1992) Pretranslational regulation of two cardiac glucose transporters in rats exposed to hypobaric hypoxia. Am. J. Physiol. 263, E562-E569
6. Daly, E. B., Wind, T., Jiang, X. M., Sun, L., and Hogg, P. J. (2004) Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases. Biochim. Biophys. Acta 1691, 17-22
7. Semenza, G. L., Roth, P. H., Fang, H. M., and Wang, G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763
8. Kim, J. W., and Dang, C. V. (2005) Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30, 142-150
9. Faik, P., Walker, J. I., Redmill, A. A., and Morgan, M. J. (1988) Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences. Nature (London) 332, 455-457
10. Watanabe, H., Takehana, K., Date, M., Shinozaki, T., and Raz, A. (1996) Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56, 2960-2963
11. Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., and Schiffmann, E. (1986) Tumor cell autocrine motility factor. Proc. Natl. Acad. Sci. USA 83, 3302-3306
12. Gurney, M. E., Apatoff, B. R., Spear, G. T., Baumel, M. J., Antel, J. P., Bania, M. B., and Reder, A. T. (1986) Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science 234, 574-581
13. Xu, W., Seiter, K., Feldman, E., Ahmed, T., and Chiao, J. W. (1996) The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood 87, 4502-4506
14. Yakirevich, E., and Naot, Y. (2000) Cloning of a glucose phosphate isomerase/neuroleukin-like sperm antigen involved in sperm agglutination. Biol. Reprod. 62, 1016-1023
15. Cao, M. J., Osatomi, K., Matsuda, R., Ohkubo, M., Hara, K., and Ishihara, T. (2000) Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem. Biophys. Res. Commun. 272, 485-489
16. Schroter, W., Eber, S. W., Bardosi, A., Gahr, M., Gabriel, M., and Sitzmann, F. C. (1985) Generalised glucosephosphate isomerase (GPI) deficiency causing haemolytic anaemia, neuromuscular symptoms and impairment of granulocytic function: a new syndrome due to a new stable GPI variant with diminished specific activity (GPI Homburg). Eur. J. Pediatr. 144, 301-305
17. Beutler, E., West, C., Britton, H. A., Harris, J., and Forman, L. (1997) Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). Blood Cells Mol. Dis. 23, 402-409
18. Matsumoto, I., Staub, A., Benoist, C., and Mathis, D. (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286, 1732-1735
19. Gomm, S. A., Keevil, B. G., Thatcher, N., Hasleton, P. S., and Swindell, R. S. (1988) The value of tumour markers in lung cancer. Br. J. Cancer 58, 797-804
20. Baumann, M., Kappl, A., Lang, T., Brand, K., Siegfried, W., and Paterok, E. (1990) The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest. 8, 351-356
21. Filella, X., Molina, R., Jo, J., Mas, E., and Ballesta, A. M. (1991) Serum phosphohexose isomerase activities in patients with colorectal cancer. Tumour Biol. 12, 360-367
22. Yoon, D. Y., Buchler, P., Saarikoski, S. T., Hines, O. J., Reber, H. A., and Hankinson, O. (2001) Identification of genes differentially induced by hypoxia in pancreatic cancer cells. Biochem. Biophys. Res. Commun. 288, 882-886
23. Niizeki, H., Kobayashi, M., Horiuchi, I., Akakura, N., Chen, J., Wang, J., Hamada, J. I., Seth, P., Katoh, H., Watanabe, H., et al. (2002) Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br. J. Cancer 86, 1914-1919
24. Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., Ferreira, G., Iyer, N., LaRusch, J., Pak, B., Taghavi, P., et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138-1143
25. Niinaka, Y., Paku, S., Haga, A., Watanabe, H., and Raz, A. (1998) Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells. Cancer Res. 58, 2667-2674
26. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (London) 411, 494-498
27. Funasaka, T., Haga, A., Raz, A., and Nagase, H. (2002) Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells. Int. J. Cancer 101, 217-223
28. Tsutsumi, S., Hogan, V., Nabi, I. R., and Raz, A. (2003) Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63, 242-249
29. Yanagawa, T., Watanabe, H., Takeuchi, T., Fujimoto, S., Kurihara, H., and Takagishi, K. (2004) Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta. Lab. Invest. 84, 513-522
30. Gleadle, J. M., Ebert, B. L., Firth, J. D., and Ratcliffe, P. J. (1995) Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. Am. J. Physiol. 268, C1362-C1368
31. Blancher, C., Moore, J. W., Robertson, N., and Harris, A. L. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61, 7349-7355
32. Yeo, E. J., Chun, Y. S., Cho, Y. S., Kim, J., Lee, J. C., Kim, M. S., and Park, J. W. (2003) YC-I: a potential anticancer drug targeting hypoxia-inducible factor I. J. Natl. Cancer Inst. 95, 516-525
33. Ko, F. N., Wu, C. C., Kuo, S. C., Lee, F. Y., and Teng, C. M. (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84, 4226-4233
34. Galle, J., Zabel, U., Hubner, U., Hatzelmann, A., Wagner, B., Wanner, C., and Schmidt, H. H. (1999) Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br. J. Pharmacol. 127, 195-203
35. Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., and van der Wall, E. (2001) Levels of hypoxia-inducible factor 1α during breast carcinogenesis. J. Natl. Cancer Inst. 93, 309-314
36. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359, 843-845
37. Visconti, R. P., Richardson, C. D., and Sato, T. N. (2002) Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. USA 99, 8219-8224
38. Pawson, T. (2002) Regulation and targets of receptor tyrosine kinases. Eur. J. Cancer 38, Suppl. 5, S3-10
39. Jans, D. A. (1994) Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J. 8, 841-847
40. Burgess, W. H., and Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606
41. Lin, Y. Z., Yao, S. Y., and Hawiger, J. (1996) Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways. J. Biol. Chem. 271, 5305-5308
42. Komi, A., Ishisaki, A., Suzuki, M., and Imamura, T. (2003) A permeable FGF-1 nuclear localization sequence peptide induces DNA synthesis independently of Ras activation. Exp. Cell Res. 283, 91-100
43. Haga, A., Niinaka, Y., and Raz, A. (2000) Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein. Biochim. Biophys. Acta 1480, 235-244
44. Abraham, J. A., Mergia, A., Whang, J. L., Tumolo, A., Friedman, J., Hjerrild, K. A., Gospodarowicz, D., and Fiddes, J. C. (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233, 545-548
45. Muesch, A., Hartmann, E., Rohde, K., Rubartelli, A., Sitia, R., and Rapoport, T. A. (1990) A novel pathway for secretory proteins? Trends Biochem. Sci. 15, 86-88
46. Rubartelli, A., and Sitia, R. (1991) Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion. Biochem. Soc. Trans. 19, 255-259